Supporting the designation of July 2022 as Uterine Fibroids Awareness Month.

This resolution expresses support for the goals and ideals of Uterine Fibroids Awareness Month. Uterine fibroids are muscular tumors that grow in the wall of the uterus and may cause pain, heavy menstrual bleeding, and reproductive issues.

Bill 117 H.Res. 879, also known as the Uterine Fibroids Awareness Month resolution, aims to designate July 2022 as Uterine Fibroids Awareness Month. Uterine fibroids are non-cancerous growths that develop in the uterus and can cause a variety of symptoms such as heavy menstrual bleeding, pelvic pain, and infertility.

The resolution highlights the importance of raising awareness about uterine fibroids, which affect millions of women in the United States. By designating July 2022 as Uterine Fibroids Awareness Month, the resolution seeks to educate the public about the prevalence of uterine fibroids, the impact they have on women's health, and the available treatment options.

The resolution also calls for increased research funding to better understand the causes of uterine fibroids and develop more effective treatments. Additionally, it encourages healthcare providers to prioritize the needs of women with uterine fibroids and provide them with comprehensive care. Overall, Bill 117 H.Res. 879 aims to bring attention to an important women's health issue and advocate for improved support and resources for those affected by uterine fibroids.